Note: Ingredients listed on restricted chemical lists
EC/CAS
1317-33-5
Name of the chemical
molybdenum disulphide
Concentration
N/A
EC/CAS
7632-00-0
Name of the chemical
Sodium nitrite
Concentration
N/A
General Information
Revision date
2006-02-28
Product name
ROYCO 22MS
Emergency telephone
800-424-9300 (United States
Icons in SDS
Company Information
company name
Chemtura Canada Co.
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Physical state : Semi-solid (grease). Hazard status This material is classified hazardous under OSHA regulations in the United States, the WHMIS Controlled Product Regulation in Canada, the NOM-018-STPS-2000 in Mexico and Brazil NBR 14725:2001. Emergency overview : WARNING! CAUSES EYE AND SKIN IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. Irritating to eyes and skin. May cause sensitization by skin contact. Avoid exposure - obtain special instructions before use. Do not get on skin or clothing. Avoid contact with eyes. Contains material that can cause target organ damage. Wash thoroughly after handling. Since the product is in paste form, the risk of exposure to a carcinogen dust is minimum, this is why the related hazard statements are not shown in this MSDS. If material is to be dried and sanded by users, the risk of inhalation of dust containing a carcinogen dust will be increased, together with the risk of cancer hazard.
Principle Routes of Exposure
Skin contact. Eye contact. Ingestion.
Potential Acute Health Effects
Inhalation Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion No known significant effects or critical hazards. Skin Irritating to skin. May cause sensitization by skin contact. Eyes Irritating to eyes.
Potential chronic health
effects : Contains material that can cause target organ damage. Carcinogenicity : See above. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Over-exposure signs/symptoms Inhalation : No specific data. Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Repeated skin exposure can produce local skin destruction or dermatitis. Repeated aggravated by over- exposure of the eyes to a low level of dust can produce eye irritation. exposure See toxicological information (section 11)
